Healthcare / Medical Care FacilitiesTokyo
$1315.00
-21.00 (-1.57%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 17%
FCF escenarios
weak_data · normalized FCF $-1.1B · quality 41.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
51/100
C
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$43.0B
P/E
13.0x
↓EV/EBITDA
8.3x
↓ROE
14.2%
↑Gross Margin
15.5%
↓Debt/Equity
0.65
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+17.1%
FCF CAGR
—
FCF margin
-2.4%
FCF / Net income
-0.38x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $46.67B · net income $2.94B · FCF $-1.11B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $46.67B | $46.67B | $47.83B | $37.89B | $29.07B |
| Net Income | $2.94B | $2.94B | $4.28B | $3.21B | $2.95B |
| EBITDA | $5.69B | $5.69B | $7.35B | $5.78B | $5.38B |
| EPS | 89.77 | 89.77 | 130.79 | 98.10 | 90.33 |
| Gross Margin | 15.5% | 15.5% | 17.4% | 18.0% | 16.0% |
| Operating Margin | 8.2% | 8.2% | 11.3% | 11.1% | 7.9% |
| Net Margin | 6.3% | 6.3% | 8.9% | 8.5% | 10.2% |
| Balance Sheet | |||||
| Debt/Equity | 0.65 | 0.65 | 0.58 | 0.87 | 0.87 |
| Current Ratio | 1.60 | 1.60 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-1.11B | $-1.11B | $6.51B | $-1.62B | $1.34B |
| Returns | |||||
| ROE | 14.2% | 14.2% | 22.9% | 21.2% | 23.7% |
| Valuation | |||||
| P/E | 12.99 | 12.99 | 12.07 | 13.10 | 11.16 |
| EV/EBITDA | 8.31 | 8.31 | 6.77 | 8.37 | 6.86 |
| P/B | 2.08 | 2.08 | 2.76 | 2.77 | 2.64 |
| Growth & Yield | |||||
| Revenue Growth | -2.4% | -2.4% | 26.2% | 30.3% | — |
| EPS Growth | -31.4% | -31.4% | 33.3% | 8.6% | — |
| Dividend Yield | 3.0% | 3.0% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
9.1%
EPS terminal req.
$116.68
Spread vs growth
-40.5%
5Y implied EPS CAGR
9.5%
EPS terminal req.
$141.19
Spread vs growth
-40.8%
10Y implied EPS CAGR
9.7%
EPS terminal req.
$227.38
Spread vs growth
-41.1%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+10.9%
Start / end P/E
9.3x → 14.6x
EPS bridge
130.79 → 89.77
Residual
-17.9%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.